ADAMTS-13 and Von Willebrand factor in relation to platelet response during plasma exchange in thrombotic thrombocytopenic purpura: a clue for disease mechanism?-Reference-Cited by-同舟云学术

ADAMTS-13 and Von Willebrand factor in relation to platelet response during plasma exchange in thrombotic thrombocytopenic purpura: a clue for disease mechanism?

Published:2009-02-11 Issue:10 Volume:88 Page:1025-1028
ISSN:0939-5555
Container-title:Annals of Hematology
language:en
Short-container-title:Ann Hematol

Author:

Kappers-Klunne M. C.,van Asten J. G.,van Vliet H. H.

Publisher

Springer Science and Business Media LLC

Subject

Hematology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00277-009-0709-7.pdf

Reference13 articles.

1. Lämmle B, Kremer Hovinga JA, Alberio L (2005) Thrombotic thrombocytopenic purpura. J Thromb Haemost 3:1663–1675. doi: 10.1111/j.1538-7836.2005.01425.x

2. Desch KC, Motto DG (2007) Thrombotic thrombocytopenic purpura in humans and mice. Arterioscler Thromb Vasc Biol 27:1901–1908. doi: 10.1161/ATVBAHA.107.145797

3. Gerritsen HE, Turecek PL, Schwarz HP, Lämmle B, Furlan M (1999) Assay of von Willebrand factor (vWF)-cleaving protease based on decreased collagen binding affinity of degraded vWF: a tool for the diagnosis of thrombotic thrombocytopenic purpura. Thromb Haemost 82:1386–1389

4. Loof A, van Vliet HHDM, Kappers-Klunne MC (2001) Low activity of von Willebrand factor-cleaving protease is not restricted to patients suffering from thrombotic thrombocytopenic purpura. Br J Haematol 112:1087–1088. doi: 10.1046/j.1365-2141.2001.02622-5.x

5. Cejka J (1982) Enzyme immunoassay for FVIII-related antigen. Clin Chem 28:1356–1358

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Long-Term Follow-Up Study in Immune-Mediated Thrombotic Thrombocytopenic Purpura: What Are the Outcomes?;Journal of Clinical Medicine;2023-11-25

2. ADAMTS-13 in the Diagnosis and Management of Thrombotic Microangiopathies;Rambam Maimonides Medical Journal;2014-10-29

3. Methodologies and Clinical Utility of ADAMTS-13 Activity Testing;Seminars in Thrombosis and Hemostasis;2010-02